In the October 2006
issue:
Focus on Family Pharma
During one week in September, three European family-controlled drug
companies sold in a single week. Read inside to see what general trends and
specific factors spurred M&A activity worth $24.6 billion.
...
Third Quarter M&A Results
237 Deals Announced Worth $74.4 Billion
The third quarter of 2006 saw a total of 237 mergers and acquisitions
announced in the health care industry. Based on revealed prices, a total of
$74.4 billion was spent to finance the quarter’s M&A activity.
...
Interview with
Eisai, Inc.
...
In The Departments
Services
-
Health Care Services
-
Deal Summaries
-
Additional Transactions
-
Transaction Updates
Technology
-
Health Care Technology
-
Deal Summaries
Additional Transactions
-
Transaction Updates
Sign up for a trial subscription and get
the current issue!
Read more about
The Health Care M&A Monthly.
Articles Archive
Companies Mentioned in this issue:
October 2006
A
ABN Amro Holding NV p4
Actavis p16
Alnylam Pharmaceuticals p11
Alphatec Spine p12
Altana AG p10
Altana Chemie AG p10
Altana Pharma AG p10
AmerisourceBergen p8
Amgen p11
AnorMED p12
Apax Partners Worldwide LLP p4
AstraZeneca p10
Atugen AG p11
Avidia p11
B
Barr Laboratories p16
Bayer AG p9
Better Living Now p9
BioLok International p12
Blackstone Group p10
Blue Care Network of Michigan p8
Blue Cross Blue Shield of Michigan p7
BMW p10
Boehringer Ingleheim p9
Braveheart Investment Group p10
Bristol-Myers Squibb p11
C
Capio AB p4
Capital Research and Management p10
Capitalink, LC p12
CareFirst p8
Catholic Health East p3
CB Richard Ellis p7
Cell Therapeutics p11
Celltech p10
Citigroup Corporate and Investment Banking p11
Crdentia Corp. p9
CSFB Private Equity p10
Cytyc Corp. p12
D
Danaher Corp. p12
Deloitte & Touche LLP p7
Deutsche Bank AG p4
Deutsche Klinik p4
E
Eisai Co. Ltd. p15
Elmcroft p7
Emdeon Business Services p11
Emdeon Corp. p11
Emdeon Practice Services p11
Enterix p4
F
First Albany Capital p12
Five Star Quality Care p7
G
Galloway Pharmacy p9
General Atlantic, LLC p11
GlaxoSmithKline p9
Goldman Sachs p9
Gulf Coast Hospital p2
H
H.J. Thomas Memorial Hospital Association p3
HCA p2
Health Advocates p8
Health Care Group p7
Health Care REIT p4
HealthpointCapital Partners p12
HealthSouth p8
HealthTran, LLC p9
Highland Financial Corp. p2
Holiday Retirement Corp. p7
Hospira p12
I
Ideal Medical Products p12
iVOW p9
K
Kindred Healthcare p3
King Pharmaceuticals p15
L
Lee Memorial Health System p2
LifePoint Hospitals p3
Ligand Pharmaceuticals p15
M
M-CARE p8
Mannheimer Swartling p4
Mayne Group p12
Mayne Pharma p12
Medegen Medical Products p12
Medical Action Industries p12
Merck KGaA p1
Mercy Hospital p3
Mercy Jeannette Hospital p3
Michigan Health Insurance Corp. p8
Millennium Pharmaceuticals p12
Morgan Stanley p4
N
NationsHealth p9
NIB Capital Private Equity p10
Nordic Capital p10
Nordic Capital Fund VI p4
Novartis p9
Nycomed Pharma Holding AS p10
O
Omnicare p9
Opica AB p4
Outlook Pointe p7
P
Pfizer p10
Pittsburgh Mercy Health System p3
Pliva d.d. p16
PMSI MSA Services p8
Primedex Health Systems p4
Q
Quality Care Solutions p11
Quark Biotech p11
Quest Diagnostics p4
Quovadx p12
R
Radiologix p4
Rotech Healthcare p2
Rothschild p10
S
Sage Group plc p11
Saint Francis Hospital p3
San Francisco Advanced Imaging Center p4
Schering AG p9
Schering-Plough Corp. p16
Schroders Investment Management Ltd. p10
Schwarz Pharma AG p10
Scient'X p12
Senior Care, Inc. p7
Senior Care Real Estate Investment Trust p7
Senior Housing Properties Trust p7
Serono, SA p1
Shadyside Hospital p3
Signature Hospital Corporation p4
Southwest Florida Regional Medical Center p2
SR Pharma plc p11
St. Francis Medical Center p3
Standard Management p9
Sunrise Senior Living p7
Sunrise Senior Living REIT p7
T
Tonkin Group p4
TriZetto Group p11
U
UCB, SA p10
United Rehab p7
University of Michigan Health System p8
UPMC p3
V
Ventana Medical Systems p12
Ventas p7
Vision Systems Ltd. p12
W
West Penn Allegheny Health System p3
Windrose Medical Properties Trust p4 |
Health Care M&A Results from the Third
Quarter of 2006
Email Editor
Based on preliminary
figures, a total of 237 mergers and acquisitions
were announced in the health care industry during the third quarter of
2006. The nine sectors of the health care services segment accounted for
136 deals, or 57% of the quarter’s total deal volume, while the four
sectors of the health care technology segment accounted for the remaining
101 transactions.
The most prolific sectors in
terms of deal volume include Long-Term Care with 38 deals, Medical Devices
with 34 and Pharmaceuticals with 27. These three sectors combined
attracted 42% of the deal volume. The contribution of individual sectors
to the quarter’s deal volume, as well as comparisons with the previous and
the year-ago quarters, appear in the table on page 3.
A combined
total of $74.4 billion was committed to finance the third quarter’s M&A
activity. Those funds were divided equally between the services ($38.3
billion, 51%) and technology ($36.1 billion, 49%) segments. The Hospital
sector posted the largest amount of any single sector, $33.5 billion,
while Biotechnology and Pharmaceuticals tied for second place with $16.0
billion apiece. The percentage contribution of each sector to the
quarter’s dollar volume appears in the chart on page 4. The quarter posted
seven billion-dollar deals, worth a combined total of $62.4 billion. One
of them, the $33 billion deal to privatize HCA (NYSE: HCA),
accounted for more than half of that amount.
Year-to-date, the health
care M&A market has seen 746 deals, worth a combined total of $185.0
billion. A total of 24 billion-dollar deals have been announced, at the
torrid rate of better than one every other week. |
|
FREE TRIAL
TO THE
HEALTH CARE M&A INFORMATION SERVICE!
If you like this article, there’s lots more
waiting for you in The Healthcare M&A Information Service. It’s the
bible of what's going on in health care M&A today.
Sign up for two free months right now! There’s no
obligation, no writing “cancel” on a bill. Happy reading!
|
|